Ren Sheng

1.7k total citations
44 papers, 1.1k citations indexed

About

Ren Sheng is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ren Sheng has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Ren Sheng's work include Receptor Mechanisms and Signaling (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Cancer-related gene regulation (5 papers). Ren Sheng is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Cancer-related gene regulation (5 papers). Ren Sheng collaborates with scholars based in China, United States and South Korea. Ren Sheng's co-authors include Wonhwa Cho, Ewa Stec, Kwang Pyo Kim, Maorong Chen, Yiwei Li, Shu‐Lin Liu, Daesung Lee, Matthew J. O’Connor, Akihiro Kusumi and Takahiro Fujiwara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Ren Sheng

42 papers receiving 1.1k citations

Peers

Ren Sheng

SURGE

ONCOL

Lisa Berglund Sweden

Per Niklas Hedde United States

Xuan Cao China

Maria Pascale Italy

Seung‐Wook Ryu South Korea

Cuiping Pan China

Rebekah L. Gundry United States

Yanliang Zhang China

Jie Wen China

Carina Palmberg Sweden

Lisa Berglund Sweden

Ren Sheng

927 ×1.3

127 ×0.6

264 ×1.5

SURGE

138 ×1.1

ONCOL

88 ×0.8

Citations per year, relative to Ren Sheng Ren Sheng (= 1×) peers Lisa Berglund

Countries citing papers authored by Ren Sheng

Since Specialization

Citations

This map shows the geographic impact of Ren Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Sheng more than expected).

Fields of papers citing papers by Ren Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Sheng. The network helps show where Ren Sheng may publish in the future.

Co-authorship network of co-authors of Ren Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ren Sheng. A scholar is included among the top collaborators of Ren Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren Sheng. Ren Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Jing, et al.. (2025). Wnt induces FZD5/8 endocytosis and degradation and the involvement of RSPO-ZNRF3/RNF43 and DVL. PubMed. 14. 1 indexed citations

Wang, Shengnan, Zexu Li, Xiaofeng Wang, et al.. (2025). Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer. Scientific Reports. 15(1). 6074–6074. 2 indexed citations

Liang, Yong, et al.. (2025). Propionate intervenes mast cell function to alleviate intestinal ischemia-reperfusion injury by regulating AhR/Notch1 pathway. Microbial Pathogenesis. 210. 108204–108204.

Zhang, Yuyan, Xinwei Wei, Ren Sheng, et al.. (2025). A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone Metabolism. International Journal of Molecular Sciences. 26(24). 12151–12151.

Zhang, Hui, Shaoqin Zheng, Chang Liu, et al.. (2024). HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation. Hepatology. 82(3). 702–721. 1 indexed citations

Zhang, Haijiao, Jiahui Lin, Shaoqin Zheng, et al.. (2024). CDKL3 is a targetable regulator of cell cycle progression in cancers. Journal of Clinical Investigation. 134(16). 4 indexed citations

Zheng, Shaoqin & Ren Sheng. (2024). The emerging understanding of Frizzled receptors. FEBS Letters. 598(16). 1939–1954. 6 indexed citations

Morales, Ana, Ren Sheng, Thomas E. Callis, et al.. (2023). Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy. Circulation Genomic and Precision Medicine. 17(1). e004028–e004028. 2 indexed citations

Zhang, Meng, et al.. (2023). Progression from prediabetes to type 2 diabetes mellitus in adolescents: a real world experience. SHILAP Revista de lepidopterología. 4. 1181729–1181729. 5 indexed citations

10.

Zheng, Shaoqin, et al.. (2023). Anti‐Pan‐Rspo Chimeric Protein‐Conjugated Albumin Nanoparticle Provides Promising Opportunities in Cancer Targeted Therapy. Advanced Healthcare Materials. 12(29). e2301441–e2301441. 7 indexed citations

11.

Liu, Jingwei, et al.. (2023). The deubiquitinase USP10 mediates crosstalk between the LKB1/AMPK axis and Wnt/β‐catenin signaling in cancer. FEBS Letters. 597(24). 3061–3071. 9 indexed citations

12.

Liu, Chao, Yining Li, Ren Sheng, et al.. (2021). Synthesis of N-methylpyridine-chlorofuranformamide analogs as novel OPG up-regulators and inhibitors of RANKL-induced osteoclastogenesis. Bioorganic Chemistry. 116. 105361–105361. 2 indexed citations

13.

Li, Yiwei, et al.. (2021). Volumetric Compression Induces Intracellular Crowding to Control Intestinal Organoid Growth via Wnt/β-Catenin Signaling. Cell stem cell. 28(1). 170–172. 18 indexed citations

14.

Sheng, Ren, et al.. (2019). Carvedilol blockage of delayed rectifier Kv2.1 channels and its molecular basis. European Journal of Pharmacology. 855. 50–55. 7 indexed citations

15.

Sheng, Ren, Yanchun Zhang, Enming Xing, et al.. (2018). Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design. Bioorganic & Medicinal Chemistry Letters. 28(15). 2599–2604. 14 indexed citations

16.

Yang, Jinfeng, et al.. (2018). Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells. European Journal of Pharmacology. 834. 206–212. 4 indexed citations

17.

Yoon, Youngdae, et al.. (2016). Fluorescence-Based In Situ Quantitative Imaging for Cellular Lipids. Methods in enzymology on CD-ROM/Methods in enzymology. 583. 19–33. 6 indexed citations

18.

Komura, Naoko, Kenichi Suzuki, Hiromune Ando, et al.. (2016). Raft-based interactions of gangliosides with a GPI-anchored receptor. Nature Chemical Biology. 12(6). 402–410. 149 indexed citations

19.

Tsukamoto, Kosuke, Thomas E. Wales, Kathleen Daniels, et al.. (2013). Noncanonical Role of the PDZ4 Domain of the Adaptor Protein PDZK1 in the Regulation of the Hepatic High Density Lipoprotein Receptor Scavenger Receptor Class B, Type I (SR-BI). Journal of Biological Chemistry. 288(27). 19845–19860. 13 indexed citations

20.

Chen, Yong, Ren Sheng, Morten Källberg, et al.. (2012). Genome-wide Functional Annotation of Dual-Specificity Protein- and Lipid-Binding Modules that Regulate Protein Interactions. Molecular Cell. 46(2). 226–237. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact